Navigation Links
New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations
Date:12/9/2010

RIDGEFIELD, Conn., Dec. 9, 2010 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced that new data from a subgroup analysis of the phase IIb/III LUX-Lung 1 trial show that afatinib (BIBW 2992) reached a four-fold extension (4.4 months vs. 1.0 month for placebo) in progression-free survival (PFS) in advanced non-small cell lung cancer (NSCLC) patients most likely to have an epidermal growth factor receptor (EGFR) mutation.(1)  The updated LUX-Lung 1 data will be presented at the Chicago Multidisciplinary Symposium in Thoracic Oncology.

The LUX-Lung 1 trial compared afatinib to placebo in 585 patients with advanced NSCLC whose disease progressed after receiving chemotherapy and a first-generation EGFR tyrosine kinase-inhibitor (TKI), gefitinib or erlotinib. In the study, afatinib did not extend the primary endpoint of overall survival in these advanced NSCLC patients.(2)  In addition, patients in the subgroup receiving afatinib did not have a statistically significant increase in overall survival compared to placebo. The authors concluded that the overall survival endpoint may have been confounded by the use of extensive subsequent systematic therapies.(2)  The subgroup included in the new analysis comprised two-thirds of all patients from the study (385/585) who were most likely to have EGFR mutations, as determined by clinical criteria based on their response to and duration of prior treatment with EGFR-TKIs.(1) These findings build upon the initial results from the LUX-Lung 1 clinical trial presented at the recent European Society for Medical Oncology (ESMO) meeting in Milan.(2)

The two most common side effects associated with treatment with afatinib in the LUX-Lung 1 trial were diarrhea (87% all grades, with 17% Grade 3) and rash/acne (79% all grades, with 14% Grade 3).  These side effects were usually well-managed by supportive care and dose reduction.(2)

"We continue to be encouraged by the findings o
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... SOUTH PLAINFIELD, N.J., Feb. 27, 2015  PTC Therapeutics, ... corporate update and reported financial results for the fourth ... "2014 was a transformative year for PTC. ... on delivering and developing RNA-targeted therapies in the rare ... Officer, PTC Therapeutics, Inc. "We are proud to bring ...
(Date:2/27/2015)... Israel , February 27, 2015 /PRNewswire/ ... baut sein bahnbrechendes Überwachungssystem für kongestive Herzinsuffizienz ... aus -     ... Technologies, die ein neuartiges Herzüberwachungssystem für Patienten ... heute bekannt, dass sie ein Finanzierungsvorhaben über ...
(Date:2/27/2015)... TORONTO , Feb. 27, 2015  Bionik Laboratories ... (the "Company"), announced today that it acquired Bionik Laboratories, ... Laboratories"), and completed the sale to qualified accredited investors ... for aggregate gross proceeds of approximately $6.2 million. Shares ... quoted on the OTC Markets under the symbol "DWTPD" ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3
... II Trial Results,For Novel Oral Thrombin Receptor ... American College Of Cardiology/i2 Summit, KENILWORTH, N.J., ... today that results of the,Phase II trial ... (TRA),SCH 530348 will be presented at the ...
... SAN CARLOS, Calif., March 19, 2007 /PRNewswire-FirstCall/ --,Nuvelo, ... ANTHEM,(Anticoagulation with rNAPc2 To Help Eliminate MACE)/TIMI 32 ... c2,(rNAPc2) in patients with non-ST-elevation acute coronary syndromes,(NSTE-ACS) ... the of,Cardiology (ACC) 56th Annual Scientific Session taking ...
Cached Medicine Technology:Media Advisory: ACC Updated Schedule 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 3
(Date:2/27/2015)... LOUIS, MO (PRWEB) February 27, 2015 "After ... believe that the benefits of prenatal spina bifida repair may ... in the 35 to 40 range," says Fetal Care ... surgeon and maternal fetal medicine specialist. "The goal of ... best care for these mothers and their unborn babies." , ...
(Date:2/27/2015)... New York, NY (PRWEB) February 27, 2015 ... Cole Tickets for his "Forest Hills Drive Tour Act ... third album "2014 Forest Hills Drive" which debuted on the ... selling hip-hop album. In March, this accomplished hip-hop artist ... begins in early March and will visit cities such as ...
(Date:2/27/2015)... According to the report, the annual revenue ... in 2013 rose by 31.9%. However, in the first ... generated by the industry was recorded at RMB3.623 billion ... industry in 2013. , View Full Report at ... oral industry as a branch of medical industry that ...
(Date:2/27/2015)... Several studies showing the promise of stem ... headline news recently. However, all these studies dealt with ... month’s STEM CELLS Translational Medicine shows that stem cells ... congenital heart diseases that can lead to heart failure. ... Mayo Clinic in Rochester, Minn., looked at the feasibility ...
(Date:2/27/2015)... February 27, 2015 Ticket Down announces that ... during the summer months of 2015. Tickets for his ... sell out at a record pace. , Ed ... TX Frank Erwin Center, Wednesday, May 6, 2015 , 5/7/15, ... Prairie, Thursday, May 7, 2015 , 5/9/15, Ed Sheeran Tickets, ...
Breaking Medicine News(10 mins):Health News:Pregnant Women with a BMI above 35 Now Eligible for Fetal Spina Bifida Repair Surgery Study at the St. Louis Fetal Care Institute 2Health News:Pregnant Women with a BMI above 35 Now Eligible for Fetal Spina Bifida Repair Surgery Study at the St. Louis Fetal Care Institute 3Health News:J. Cole Tickets in Los Angeles, Mountain View, Chula Vista, New York, Chicago, Indianapolis, Holmdel, Dallas, Seattle, Camden, Bristow, Atlanta, Houston & Detroit On Sale 2Health News:J. Cole Tickets in Los Angeles, Mountain View, Chula Vista, New York, Chicago, Indianapolis, Holmdel, Dallas, Seattle, Camden, Bristow, Atlanta, Houston & Detroit On Sale 3Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 3Health News:Study Shows Stem Cells Have Potential to Help Kids’ Hearts, Too 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 3Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 4
... Younger at American Society of ... Plastic Surgeons Annual Meeting, BALTIMORE, Oct. 28 ... to looking younger. In fact,plastic surgeons analyze facial features and configurations ... in, say,presenters today at the American Society of Plastic Surgeons (ASPS) ...
... diagnosis is vital; symptoms can often mimic digestive problems , , ... had a reputation as a silent killer, because many people ... But women suffering from the disease knew differently. They knew ... patient. , "Survivors for years have said there are symptoms ...
... a condition called gastroschisis varies greatly by hospital, according to ... have a hole in their abdomen near the umbilical cord. ... the only abdominal anomaly, is fairly easy to repair, and ... suggest that in some hospitals, far fewer babies who should ...
... men born with a severe urological anomaly in which ... more robust sexual lives than women born with the ... urologists at the Johns Hopkins Childrens Center. The condition, ... surgeries throughout infancy and childhood and into early adolescence.The ...
... Four More Years of Borrowing for Iraq War,and Denying ... Howard Dean,Chairman of the Democratic National Committee, delivered the ... while all of the,Republican presidential candidates support borrowing $196 ... $7 billion next year for the,bipartisan plan to provide ...
... ... Meeting, BALTIMORE, Oct. 27 ... are making headlines. But are these procedures really ready to,be a part ... new discoveries or just "buyer beware" marketing,hype this week at the American ...
Cached Medicine News:Health News:Facelift, Botox, or Both? Depends Upon Your Decade of Life 2Health News:Facelift, Botox, or Both? Depends Upon Your Decade of Life 3Health News:New Guidelines Should Improve Ovarian Cancer Detection 2Health News:New Guidelines Should Improve Ovarian Cancer Detection 3Health News:Democratic Radio Address 2Health News:Democratic Radio Address 3Health News:Non-Invasive Fat-Melting Procedures - Hype or Reality? 2
... liquid handling capability allows you to ... 5 nanoliters. Precision robotics and flexible ... so youll hit your target every ... without an air gap, providing increased ...
... System Genesis NPS based on the well-known ... to miniaturize your assays for high throughput ... direct dilutions., Furthermore it is an ... gene expression analysis, gene mapping, SNP detection ...
... Automatic dispenser for low volumes. Dispenses volumes ... -well format. Fast throughput of less than ... The dispenser features an intuitive user interface ... used to dispense liquids and suspensions, beads, ...
... dispensing of reagents, buffers and solvents for ... through eight nozzle manifolds for fast throughput. ... dispensing one, two or four reagents into ... from 200 nL to 2.0 mL with ...
Medicine Products: